{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:44:24Z","timestamp":1791204264753,"version":"4.2.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T00:00:00Z","timestamp":1725753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-06318 JL"],"award-info":[{"award-number":["2020-06318 JL"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.thromres.2024.109135","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T11:49:33Z","timestamp":1725018573000},"page":"109135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Tocilizumab reduces hypercoagulation in COVID-19 \u2013 Perspectives from the coagulation and immunomodulation Covid assessment (Coag-ImmCovA) clinical trial"],"prefix":"10.1016","volume":"243","author":[{"given":"Lou M.","family":"Almskog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sj\u00f6str\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Sund\u00e9n-Cullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Taxiarchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"\u00c5gren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Freyland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"B\u00f6rjesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta","family":"Wikman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl Magnus","family":"Wahlgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wanecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovan","family":"Antovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Lampa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2024.109135_bb0005","author":"World Health Organization"},{"issue":"1","key":"10.1016\/j.thromres.2024.109135_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jamainternmed.2020.6615","article-title":"Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial","volume":"181","author":"Salvarani","year":"2021","journal-title":"JAMA Intern. Med."},{"issue":"5","key":"10.1016\/j.thromres.2024.109135_bb0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: immunopathology and its implications for therapy","volume":"20","author":"Cao","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"suppl_1","key":"10.1016\/j.thromres.2024.109135_bb0020","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/ajhp\/59.suppl_1.S3","article-title":"Pathophysiology of sepsis","volume":"59","author":"Jacobi","year":"2002","journal-title":"Am. J. Health-Syst. Pharm."},{"issue":"3","key":"10.1016\/j.thromres.2024.109135_bb0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000505099","article-title":"Interleukin-6: a masterplayer in the cytokine network","volume":"98","author":"Uciechowski","year":"2020","journal-title":"Oncology"},{"issue":"14","key":"10.1016\/j.thromres.2024.109135_bb0030","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2024.109135_bb0035","first-page":"4","article-title":"The central role of anti-IL-1 blockade in the treatment of monogenic and multi-factorial autoinflammatory diseases","author":"Federici","year":"2013","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.thromres.2024.109135_bb0040","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/1744666X.2019.1629904","article-title":"Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome","volume":"15","author":"Kotch","year":"2019","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"10","key":"10.1016\/j.thromres.2024.109135_bb0045","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/s41591-021-01499-z","article-title":"Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial","volume":"27","author":"Kyriazopoulou","year":"2021","journal-title":"Nat. Med."},{"issue":"10285","key":"10.1016\/j.thromres.2024.109135_bb0050","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","author":"Abbas","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.thromres.2024.109135_bb0055","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/blood.2020006941","article-title":"Impact of anticoagulation prior to COVID-19 infection: a propensity score\u2013matched cohort study","volume":"136","author":"Tremblay","year":"2020","journal-title":"Blood"},{"issue":"S1","key":"10.1016\/j.thromres.2024.109135_bb0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/ijlh.13547","article-title":"COVID-19\u2013related laboratory coagulation findings","volume":"43","author":"Devreese","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"issue":"08","key":"10.1016\/j.thromres.2024.109135_bb0065","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1055\/a-1366-9656","article-title":"Prevalence and predictors of venous thromboembolism or mortality in hospitalized COVID-19 patients","volume":"121","author":"Cohen","year":"2021","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109135_bb0070","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","article-title":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"issue":"8","key":"10.1016\/j.thromres.2024.109135_bb0075","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/jama.2020.13372","article-title":"Thrombosis in hospitalized patients with COVID-19 in a New York City health system","volume":"324","author":"Bilaloglu","year":"2020","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.thromres.2024.109135_bb0080","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1055\/a-1477-3829","article-title":"Platelet count rose while D-dimer levels dropped as deaths and thrombosis declined\u2014an observational study on anticoagulation shift in COVID-19","volume":"121","author":"Sj\u00f6str\u00f6m","year":"2021","journal-title":"Thromb. Haemost."},{"issue":"01","key":"10.1016\/j.thromres.2024.109135_bb0085","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1055\/a-1725-9221","article-title":"Hypercoagulation detected by rotational thromboelastometry predicts mortality in COVID-19: a risk model based on a prospective observational study","volume":"06","author":"Almskog","year":"2022","journal-title":"TH Open."},{"key":"10.1016\/j.thromres.2024.109135_bb0090","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2021.211026","article-title":"Assessment of coagulation profiles by rotational thromboelastometry in COVID 19 patients","author":"Elaa","year":"2022","journal-title":"Clin Lab [Internet]."},{"issue":"06","key":"10.1016\/j.thromres.2024.109135_bb0095","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1055\/s-0040-1710018","article-title":"COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure","volume":"120","author":"Spiezia","year":"2020","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2024.109135_bb0100","article-title":"The evaluation of overall hemostatic potential assay in patients with COVID -19 infection","volume":"44","author":"Lee","year":"2022","journal-title":"Int J Lab Hematol [Internet]"},{"issue":"10","key":"10.1016\/j.thromres.2024.109135_bb0105","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1111\/jth.15806","article-title":"The suboptimal fibrinolytic response in COVID-19 is dictated by high PAI-1","volume":"20","author":"Whyte","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109135_bb0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.thromres.2022.03.013","article-title":"Associations between hemostatic markers and mortality in COVID-19 \u2013 compounding effects of D-dimer, antithrombin and PAP complex","volume":"213","author":"Bokn\u00e4s","year":"2022","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2024.109135_bb0115","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1469-7793.2001.0171j.x","article-title":"Role of endogenous interleukin-1 receptor antagonist in regulating fever induced by localised inflammation in the rat","volume":"531","author":"Cartmell","year":"2001","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.thromres.2024.109135_bb0120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12969-021-00585-3","article-title":"Intravenous administration of anakinra in children with macrophage activation syndrome","volume":"19","author":"Phadke","year":"2021","journal-title":"Pediatr. Rheumatol."},{"issue":"11","key":"10.1016\/j.thromres.2024.109135_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-063856","article-title":"Investigating the association between IL-6 antagonist therapy and blood coagulation in critically ill patients with COVID-19: a protocol for a prospective, observational, multicentre study","volume":"12","author":"Kov\u00e1cs","year":"2022","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.thromres.2024.109135_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002359","article-title":"A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases","volume":"8","author":"Kastrati","year":"2022","journal-title":"RMD Open"},{"issue":"5","key":"10.1016\/j.thromres.2024.109135_bb0135","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","article-title":"Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19","volume":"21","author":"Bonaventura","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.thromres.2024.109135_bb0140","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.thromres.2024.109135_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0295838","article-title":"Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): a randomized, controlled, open-label trial. Ray A, editor","volume":"18","author":"Sund\u00e9n-Cullberg","year":"2023","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.thromres.2024.109135_bb0150","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MBC.0000000000000971","article-title":"Derangement of the coagulation process using subclinical markers and viscoelastic measurements in critically ill patients with coronavirus disease 2019 pneumonia and non-coronavirus disease 2019 pneumonia","volume":"32","author":"Pavoni","year":"2021","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"2","key":"10.1016\/j.thromres.2024.109135_bb0155","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ajh.23599","article-title":"TEG and ROTEM: technology and clinical applications","volume":"89","author":"Whiting","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"07","key":"10.1016\/j.thromres.2024.109135_bb0160","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1055\/s-0030-1265294","article-title":"The overall hemostasis potential: a laboratory tool for the investigation of global hemostasis","volume":"36","author":"Antovic","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2024.109135_bb0165","article-title":"Extracellular vesicles in plasma and cerebrospinal fluid in patients with COVID-19 and neurological symptoms","author":"Taxiarchis","year":"2023","journal-title":"Int. J. Lab. Hematol."},{"issue":"1","key":"10.1016\/j.thromres.2024.109135_bb0170","article-title":"Scanning electron microscopy","volume":"25","author":"Fischer","year":"2012","journal-title":"Curr Protoc Microbiol [Internet]"},{"key":"10.1016\/j.thromres.2024.109135_bb0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.thromres.2017.04.005","article-title":"Blood clot parameters: thromboelastography and scanning electron microscopy in research and clinical practice","volume":"154","author":"Pretorius","year":"2017","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2024.109135_bb0180","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.biomaterials.2015.05.015","article-title":"DiameterJ: a validated open source nanofiber diameter measurement tool","volume":"61","author":"Hotaling","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.thromres.2024.109135_bb0185","article-title":"COVID-19 and sepsis are associated with different abnormalities in plasma procoagulant and fibrinolytic activity","author":"Bouck","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol [Internet]"},{"issue":"9","key":"10.1016\/j.thromres.2024.109135_bb0190","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/jth.15016","article-title":"Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis","volume":"18","author":"Nougier","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"18","key":"10.1016\/j.thromres.2024.109135_bb0195","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1182\/blood-2010-11-316885","article-title":"Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice","volume":"117","author":"Machlus","year":"2011","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.thromres.2024.109135_bb0200","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2174\/1389450123666220826162900","article-title":"Fibrinogen, fibrin, and fibrin degradation products in COVID-19","volume":"23","author":"Kangro","year":"2022","journal-title":"Curr. Drug Targets"},{"issue":"3","key":"10.1016\/j.thromres.2024.109135_bb0205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/157340308785160570","article-title":"Roles of IL-6-gp130 signaling in vascular inflammation","volume":"4","author":"Hou","year":"2008","journal-title":"Curr. Cardiol. Rev."},{"issue":"6","key":"10.1016\/j.thromres.2024.109135_bb0210","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/art.20303","article-title":"Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial","volume":"50","author":"Nishimoto","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.thromres.2024.109135_bb0215","article-title":"Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19","volume":"190","author":"Maquet","year":"2020","journal-title":"Br J Haematol [Internet]."},{"issue":"05","key":"10.1016\/j.thromres.2024.109135_bb0220","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/a-1581-4355","article-title":"Platelets and COVID-19","volume":"41","author":"Rohlfing","year":"2021","journal-title":"H\u00e4mostaseologie"},{"issue":"1","key":"10.1016\/j.thromres.2024.109135_bb0225","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0049-3848(75)90135-8","article-title":"Dynamic coagulation studies: influence of normal and abnormal platelets on clot structure formation","volume":"7","author":"Glover","year":"1975","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2024.109135_bb0230","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1182\/bloodadvances.2021004816","article-title":"Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19","volume":"6","author":"Wygrecka","year":"2022","journal-title":"Blood Adv."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824002676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824002676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:26:18Z","timestamp":1777472778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824002676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":46,"alternative-id":["S0049384824002676"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109135","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.05.31.24308108","asserted-by":"object"}]},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tocilizumab reduces hypercoagulation in COVID-19 \u2013 Perspectives from the coagulation and immunomodulation Covid assessment (Coag-ImmCovA) clinical trial","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109135"}}